Sugi Predict

Sugi Predict / Compounds / SCHEMBL25340802

SCHEMBL25340802

SCHEMBL25340802

CCCCCc1cc(O)c(CC=C(C)CCC=C(C)C)c(OCC)c1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 2/20 0.82
▸ CNR2 P34972 2/20 0.82
▸ TRPV1 Q8NER1 2/20 0.82
▸ PPARG P37231 5/20 0.80
▸ SLC6A3 Q01959 2/20 0.80
▸ TRPA1 O75762 1/20 0.80
▸ INHA P05111 1/20 0.80
▸ SLC6A2 P23975 1/20 0.80
▸ HTR2A P28223 1/20 0.80
▸ SLC6A4 P31645 1/20 0.80
▸ OPRM1 P35372 1/20 0.80
▸ KCNH2 Q12809 1/20 0.80
▸ TRPM8 Q7Z2W7 1/20 0.80
▸ TRPV3 Q8NET8 1/20 0.80
▸ TRPV4 Q9HBA0 1/20 0.80
▸ TRPV2 Q9Y5S1 1/20 0.80
▸ TRPM7 Q96QT4 1/20 0.55
▸ DAGLA Q9Y4D2 1/20 0.55
▸ PTPN1 P18031 2/20 0.53
▸ BACE1 P56817 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24997806 1.00 CNR1 (0.82) CNR1CNR2TRPV1PPARGSLC6A3
SCHEMBL24997668 0.94 PPARG (0.78) CNR1CNR2TRPV1PPARGSLC6A3
SCHEMBL25341683 0.94 PPARG (0.78) CNR1CNR2TRPV1PPARGSLC6A3
SCHEMBL24997663 0.93 PPARG (0.77) CNR1CNR2TRPV1PPARGSLC6A3
SCHEMBL25342417 0.93 PPARG (0.77) CNR1CNR2TRPV1PPARGSLC6A3
SCHEMBL24997803 0.93 CNR1 (0.73) CNR1CNR2TRPV1PPARGSLC6A3
SCHEMBL25342074 0.93 CNR1 (0.73) CNR1CNR2TRPV1PPARGSLC6A3
SCHEMBL23500061 0.93 PPARG (0.72) CNR1CNR2TRPV1PPARGSLC6A3
SCHEMBL23500059 0.93 PPARG (0.72) CNR1CNR2TRPV1PPARGSLC6A3
SCHEMBL23500051 0.91 PPARG (0.73) CNR1CNR2TRPV1PPARGSLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12433903-B2 Cannabinoid derivatives and their use DEMEETRA AGBIO, INC. (US) 2025-10-07 — — US disclosed
US-11992497-B2 Cannabinoid derivatives and their use DEMEETRA AGBIO, INC. (US) 2024-05-28 — — US disclosed
US-20230322654-A1 CANNABINOID DERIVATIVES AND THEIR USE DEMEETRA AGBIO, INC. 2023-10-12 — — US disclosed
US-20230248748-A1 CANNABINOID DERIVATIVES AND THEIR USE DEMEETRA AGBIO, INC. 2023-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12433903-B2 Cannabinoid derivatives and their use CNR1, CNR2, FAAH CNR1 1/4885CNR2 2/4885TRPV1 16/4885
US-20230248748-A1 CANNABINOID DERIVATIVES AND THEIR USE CNR1, CNR2, FAAH CNR1 1/4885CNR2 2/4885TRPV1 16/4885
US-11992497-B2 Cannabinoid derivatives and their use CNR1, CNR2, FAAH CNR1 1/4885CNR2 2/4885TRPV1 16/4885
US-20230322654-A1 CANNABINOID DERIVATIVES AND THEIR USE CNR1, CNR2, FAAH CNR1 1/4885CNR2 2/4885TRPV1 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.